Swipe om te navigeren naar een ander artikel
We examined behaviour management problems as predictors of psychotropic medication, use of psychiatric consultation and in-patient admission in a group of 66 adults with pervasive developmental disorder (PDD) and intellectual disability (ID) and 99 controls matched in age, gender and level of ID. Overall, people with PDD had higher rates of most DAS behaviour problems and more frequent use of anti-psychotics than matched controls. Logistic regression analyses showed that physical aggression and problems such as pestering staff independently predicted use of anti-psychotics. Physical aggression and overactivity predicted further involvement of psychiatric services. PDD diagnosis predicted admission to an in-patient unit. The results suggest that externalizing problem behaviours in adults with autism can predict type of treatment intervention.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Aman, M.G., Sarphare, G., & Burrow, W. H. (1995). Psychotropic drug use in group homes: prevalence and relation to demographic / psychiatric variables. American Journal on Mental Retardation, 99, 500–509. PubMed
Bouras N. (eds), (1999). Psychiatric and behavioural disorders in developmental disabilities and mental retardation. Cambridge: Cambridge University Press.
Carr, E. G., Horner, R., & Turnbull, A. P. (1999). Positive behaviour support in people with developmental disabilities: a research synthesis (Monograph (American Association on Mental Retardation). Washington, DC: American Association on Mental Retardation.
Didden, R., Duker, P. C., & Korzilius, H. (1999). Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation. American Journal of Mental Retardation, 101, 387–399.
Dinca, O., Paul, M., & Spencer, N. J. (2005). Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders. Journal of Psychopharmacology, 19, 521–532. PubMedCrossRef
Hanson, R. H., Weiseler, N. A., Lakin, C., & Braddock, D. L. (2002). Crisis prevention and response in the community. Washington, DC: AAMR.
Howlin, P. (1997). Autism: preparation for adulthood. London: Routledge.
Kwok, H. W. M. (2003). Psychopharmacology in autism spectrum disorders. Current Opinion in Psychiatry, 16, 529–534. CrossRef
New York Department of Health (1999). Clinical practice guidelines: The guideline technical report. Autism / Pervasive Developmental Disorders. Assessment and inte4rvention for young children (age 0–3 year). Publication number 4217. Albany: New York Department of Health.
Scotti, J. R., Evans, I. M., Meyer, L. H., & Walker, P. (1991). A meta-analysis of intervention research with problem behavior: treatment validity and standards of practice. American Journal on Mental Retardation, 96, 233–256. PubMed
- Behaviour Management Problems as Predictors of Psychotropic Medication and Use of Psychiatric Services in Adults with Autism
- Kluwer Academic Publishers-Plenum Publishers